Historique
Détail de l'auteur
Documents disponibles écrits par cet auteur (16)
Ajouter le résultat à votre sélection Affiner la recherche
J. M. CORKERY ; S. ELLIOTT ; F. SCHIFANO ; O. CORAZZA ; A. H. GHODSE | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : Périodique2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops as 'legal highs', 'rese[...]
C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO | 2012
Dans Human Psychopharmacology: Clinical and Experimental (Vol.27, n°2, March 2012) Article : PériodiqueOBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]
J. M. CORKERY ; H. CLARIDGE ; C. GOODAIR ; F. SCHIFANO | 2017
Dans Journal of Psychopharmacology (Vol.31, n°8, August 2017) Article : PériodiqueCocaine-related deaths have increased since the early 1990s in Europe, including the UK. Being multi-factorial, they are difficult to define, detect and record. The European Monitoring Centre for Drugs and Drug Addiction commissioned research to[...]
G. MENA ; I. GIRAUDON ; E. ALVAREZ ; J. M. CORKERY ; J. MATIAS ; K. GRASAASEN ; N. LLORENS ; P. GRIFFITHS ; J. VICENTE | 2013
Dans European Addiction Research (Vol.19, n°2, February 2013) Article : PériodiqueBackground: Cocaine-related health consequences are difficult to observe. Data on drug users in health-emergency settings may be a useful source of information on consequences that are not visible via other information sources. Methods: Thirty[...]
B. LOI ; J. M. CORKERY ; H. CLARIDGE ; C. GOODAIR ; S. CHIAPPINI ; C. GIMENO CLEMENTE ; F. SCHIFANO | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°4, July 2015) Article : PériodiqueObjective: Mephedrone is a stimulant drug chemically related to amphetamine, with effects similar to those of amphetamine and cocaine. This study aims to analyse fatalities following ingestion of mephedrone in the UK amongst 16- to 24-year-olds [...]
J. M. CORKERY ; F. SCHIFANO ; G. MARTINOTTI | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : PériodiqueNovel psychoactive substances (NPS), especially those newly created, are largely an unknown quantity, particularly in terms of their potential serious adverse effects. This means that policy-makers and clinicians are under-informed about appropr[...]
V. CATALANI ; D. ARILLOTTA ; J. M. CORKERY ; A. GUIRGUIS ; A. VENTO ; F. SCHIFANO | 2021
Dans Frontiers in Psychiatry (Vol.11, 2021) Article : PériodiqueCOVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. Th[...]
J. M. CORKERY, Auteur ; F. SCHIFANO, Auteur ; A. H. GHODSE, Auteur ; L. GALLELLI, Éditeur scientifique | 2012
ChapitreThe misuse of mephedrone (4-methylmethcathinone) has been increasing greatly in Western countries over the last two years or so, especially in the club and dance scenes. This period has also been marked by claims that the substance has been impl[...]
S. CHIAPPINI ; H. CLARIDGE ; J. M. CORKERY ; C. GOODAIR ; B. LOI ; F. SCHIFANO | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°4, July 2015) Article : PériodiqueObjective: The goal of this study is to provide an update on the data given on methoxetamine (MXE)-related fatalities that occurred in 2011-2013, presented at the Second International Conference on Novel Psychoactive Substances. Methods: Fatali[...]
D. ARILLOTTA ; F. SCHIFANO ; F. NAPOLETANO ; C. ZANGANI ; L. GILGAR ; A. GUIRGUIS ; J. M. CORKERY ; E. AGUGLIA ; A. VENTO | 2020
Dans Frontiers in Neuroscience (Vol.14, 2020) Article : PériodiqueBackground: A wide range of novel psychoactive substances (NPSs) are regularly searched and discussed online by e-psychonauts. Among NPSs, the range of prescription/non-prescription opioids (fentanyl and non-fentanyl analogs) and herbal derivati[...]
FRANÇAIS : L'auteur fait trois constats: 1) l'usage de la cocaïne et du crack chez les 16-24 ans était constant au Royaume-Uni entre 1994 et 1996, mais a fortement augmenté entre 1996 et 1998. Les morts liées à la cocaïne ont augmenté de 2,5% p[...]
F. SCHIFANO ; F. NAPOLETANO ; D. ARILLOTTA ; C. ZANGANI ; L. GILGAR ; A. GUIRGUIS ; J. M. CORKERY ; A. VENTO | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : PériodiqueAims: Within the new psychoactive substances (NPS) scenario, several hundred different molecules, mostly including synthetic cannabinoids and cathinones, have been identified so far. The aims of the paper were to: (i) identify the number of synt[...]
J. M. CORKERY ; F. SCHIFANO ; A. H. GHODSE ; A. OYEFESO | 2004
Dans Human Psychopharmacology: Clinical and Experimental (Vol.19, n°8, December 2004) Article : PériodiqueMethadone is a synthetic opioid, used both as an analgesic in severe pain relief and now mainly in the treatment of opiate dependence. Such use of the drug has increased as its advantages have become widely recognized. There are undesirable outc[...]
